Skip to content

Alaunos Therapeutics, Inc.: filings

Every Alaunos Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 202631950001193125-26-352421
10-Q2026-05-15fiscal Q1 202629620001193125-26-227272
10-K2026-03-31fiscal FY 202538780001193125-26-134720
10-Q2025-11-14fiscal Q3 2025341010001193125-25-282988
10-Q2025-08-14fiscal Q2 202530920000950170-25-108887
10-Q2025-05-15fiscal Q1 202528600000950170-25-072709
10-K2025-03-31fiscal FY 202439790000950170-25-047758
10-Q2024-11-14fiscal Q3 2024351040000950170-24-126793
10-Q2024-08-14fiscal Q2 2024351050000950170-24-097142
10-Q2024-05-15fiscal Q1 202435740000950170-24-060075
10-K2024-04-01fiscal FY 202343870000950170-24-038868
10-Q2023-11-14fiscal Q3 2023391120000950170-23-063354
10-Q2023-08-14fiscal Q2 2023381100000950170-23-042486
10-Q2023-05-10fiscal Q1 202337780000950170-23-020088
10-K2023-03-07fiscal FY 202244880000950170-23-006377
10-Q2022-11-14fiscal Q3 2022381100000950170-22-024695
10-Q2022-08-15fiscal Q2 2022361040000950170-22-017225
10-Q2022-05-16fiscal Q1 202230640000950170-22-009942
10-K2022-03-30fiscal FY 202137740000950170-22-004972
10-Q2021-11-08fiscal Q3 202131820000950170-21-003463
10-Q2021-08-13fiscal Q2 202129770000950170-21-001446
10-Q2021-05-06fiscal Q1 202129610001193125-21-153365
10-K2021-03-01fiscal FY 2020401360001193125-21-063387
10-Q2020-11-05fiscal Q3 202030780001193125-20-286807
10-Q2020-08-06fiscal Q2 202030780001193125-20-211865
10-Q2020-05-07fiscal Q1 202029600001193125-20-136200
10-K2020-03-02fiscal FY 2019421370001193125-20-058863
10-Q2019-11-07fiscal Q3 201933840001193125-19-287259
10-Q2019-08-08fiscal Q2 201933840001193125-19-216056
10-Q2019-05-08fiscal Q1 201933670001193125-19-141382
10-K2019-03-05fiscal FY 2018401350001193125-19-063978
10-Q2018-11-09fiscal Q3 201831790001193125-18-323155
10-Q2018-08-08fiscal Q2 201830770001193125-18-242705
10-Q2018-05-10fiscal Q1 201823490001193125-18-159174
10-K2018-03-01fiscal FY 201728860001193125-18-067077
10-Q2017-11-06fiscal Q3 201724620001193125-17-334249
10-Q2017-07-31fiscal Q2 201724620001193125-17-242331
10-Q2017-05-01fiscal Q1 201722460001193125-17-151749
10-K2017-02-16fiscal FY 201627820001193125-17-046668
10-Q2016-11-09fiscal Q3 201624630001193125-16-764305
10-Q2016-08-09fiscal Q2 201623590001193125-16-676724
10-Q2016-05-10fiscal Q1 201622450001193125-16-585559
10-K2016-02-24fiscal FY 201526790001193125-16-475875
10-Q2015-11-02fiscal Q3 201523580001193125-15-362281
10-Q2015-08-10fiscal Q2 201524590001193125-15-284805
10-Q2015-05-07fiscal Q1 201523470001193125-15-177165
10-K2015-02-26fiscal FY 201426800001193125-15-065956
10-Q2014-10-30fiscal Q3 201423600001193125-14-389572
10-Q2014-08-07fiscal Q2 201423600001193125-14-300632
10-Q2014-05-08fiscal Q1 201422550001193125-14-189905
10-K2014-03-03fiscal FY 2013291400001193125-14-080282
10-Q2013-10-22fiscal Q3 201326760001193125-13-406591
10-Q2013-08-08fiscal Q2 201326760001193125-13-326769
10-Q2013-05-07fiscal Q1 201326640001193125-13-204366
10-K2013-03-18fiscal FY 2012301420001193125-13-112464
10-Q2012-11-08fiscal Q3 201230940001144204-12-060430
10-Q/A2012-08-28fiscal Q2 201230920001144204-12-048414
10-Q2012-05-03fiscal Q1 201226660001144204-12-025871
10-K2012-02-29fiscal FY 201126920001144204-12-012003
10-Q2011-11-03fiscal Q3 201128850001144204-11-061165
10-Q/A2011-08-09fiscal Q2 201128850001144204-11-045014
10-Q2011-08-01fiscal Q3 201028840001144204-11-042988

Inspect the source

Entity
Alaunos Therapeutics, Inc. / CIK 0001107421
Captured
2026-09-20T05:23:32.946Z
SEC response SHA-256
ceac768c7325f34d0f6470e00f80e7e6787b28f3ae115ba65aa7cdfdab90d956

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001107421.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))